【レポートの概要(一部)】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Product Profiles
05.1.1 Nexavar
05.1.2 Avastin
05.1.3 Votrient
05.1.4 Afinitor/Votubia
05.1.5 Proleukin
05.1.6 Inlyta
05.1.7 Sutent
05.1.8 Torisel
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.1.1 Types of Kidney Cancer
07.1.2 Benign Kidney Tumors
07.2 Risk Factors
07.2.1 Lifestyle and Job-related Risk Factors
07.2.2 Genetic and Hereditary Risk Factors
07.2.3 Other Risk Factors
07.3 Etiology and Pathogenesis
07.3.1 Inherited Gene Mutations
07.3.2 Acquired Gene Mutations
07.4 Signs and Symptoms
07.5 Diagnosis
07.5.1 Medical History and Physical Exam
07.5.2 Lab Tests
07.5.3 Imaging Tests
07.5.4 Biopsy
07.6 Staging
07.6.1 TNM Staging System
07.7 Management
07.7.1 Surgery
07.7.2 Ablation and Other Local Therapies
07.7.3 Radiation Therapy
07.7.4 Targeted Therapy
07.7.5 Biologic Therapy (Immunotherapy)
07.7.6 Chemotherapy
07.8 Epidemiology
07.9 Economic Burden
08.Pipeline Analysis
08.1 Key Information on Pipeline Candidates
08.1.1 AGS-003
08.1.2 Rencarex
08.1.3 Cometriq
08.1.4 IMA901
08.1.5 AV-951
08.1.6 TroVax
08.1.7 MPDL3280A
08.1.8 Opdivo
08.1.9 Naptumomab Estafenatox
08.1.10 Carfilzomib
09.Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10.Market Segmentation by Molecule Type
10.1 Small Molecules
10.2 Biologics
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and Their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and Their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Bayer
19.2.2 F. Hoffmann-La Roche
19.2.3 GlaxoSmithKline
19.2.4 Novartis
19.2.5 Pfizer
19.3 Other and Future Prominent Vendors
20.Global Kidney Cancer Drugs Market: Key Takeaways
21.Key Vendor Analysis
21.1 Bayer
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2014
21.1.4 Business Segmentation by Revenue 2013 and 2014
21.1.5 Geographical Segmentation by Revenue 2014
21.1.6 Business Strategy
21.1.7 Recent Developments
21.1.8 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2014
21.3.4 Business Segmentation by Revenue 2013 and 2014
21.3.5 Geographical Segmentation by Revenue 2014
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Novartis
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Pfizer
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
22.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Kidney Cancer
Exhibit 3: Types of Benign Kidney Tumor
Exhibit 4: Prevalence of Kidney Cancer by Gender
Exhibit 5: Global Kidney Cancer Drugs Market: Pipeline Portfolio
Exhibit 6: Global Kidney Cancer Drugs Market 2014-2019 ($ billions)
Exhibit 7: Segmentation of Global Kidney Cancer Drugs Market by Molecule Type
Exhibit 8: Segmentation of Global Kidney Cancer Drugs Market by Geography 2014
Exhibit 9: Major Drivers in Global Kidney Cancer Drugs Market
Exhibit 10: Major Challenges in Global Kidney Cancer Drugs Market
Exhibit 11: Major Trends of Global Kidney Cancer Drugs Market
Exhibit 12: Bayer: YoY Growth and Revenue of Nexavar 2010-2014 ($ millions)
Exhibit 13: F. Hoffmann-La Roche: YoY Growth and Revenue of Avastin 2010-2014 ($ millions)
Exhibit 14: GlaxoSmithKline: YoY Growth and Revenue of Votrient 2010-2014 ($ millions)
Exhibit 15: GlaxoSmithKline: Revenue of Votrient by Region 2010-2014 ($ millions)
Exhibit 16: Novartis: YoY Growth and Revenue of Afinitor 2010-2014 ($ millions)
Exhibit 17: Novartis: Revenue of Afinitor by Region 2012-2013 ($ millions)
Exhibit 18: Novartis: YoY Growth and Revenue of Proleukin 2012-2014 ($ millions)
Exhibit 19: Pfizer: YoY Growth and Revenue of Inlyta 2012-2014 ($ millions)
Exhibit 20: Pfizer: YoY Growth and Revenue of Sutent 2010-2014 ($ millions)
Exhibit 21: Global Kidney Cancer Drugs Market: Key Takeaways
Exhibit 22: Bayer: Business Segmentation by Revenue 2014
Exhibit 23: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 24: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 25: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 26: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 27: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 28: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 29: GlaxoSmithKline: Business Segmentation by Revenue 2014
Exhibit 30: GlaxoSmithKline: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical Segmentation by Revenue 2014
Exhibit 32: Novartis: Business Segmentation
Exhibit 33: Novartis: Revenue by Business Segmentation 2013
Exhibit 34: Novartis: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 35: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 36: Pfizer: Business Segmentation by Revenue 2014
Exhibit 37: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 38: Pfizer: Geographical Segmentation by Revenue 2014
【レポート販売概要】
■ タイトル:腎臓がん治療薬の世界市場2015-2019■ 英文:Global Kidney Cancer Drugs Market 2015-2019
■ 発行日:2015年7月1日
■ 調査会社:Technavio
■ 商品コード:IRTNTR6298
■ 調査対象地域:グローバル
- 医療機器業界のM&A及び投資動向(月別):December 2013Medical Equipment Monthly Deals Analysis: December 2013 - M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: December 2013 - M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt o …
- Perpetual Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Perpetual Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Perpetual Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 自動車内装材の世界市場:プラスチック、織物、皮革、ガラス、スチールAbout automotive interior materials Automotive interior materials enhance the ambience of automobiles. They are designed to offer comfort and riding pleasure to end-users. There are a number of factors that need to be looked into while designing a material to suit the tastes of customers as well as the automobile itself. Automobile interior materials find wide-ranging application in all kinds of p …
- 遠隔患者監視装置の世界市場分析:製品別(生存兆候モニター、専門モニター)、エンドユーザー別(病院の患者、その他(外来患者、在宅医療))、用途別、セグメント予測、2014-2025Global remote patient monitoring devices market is expected to reach USD 1.9 billion by 2025, according to a new report by Grand View Research Inc. Remote patient monitoring devices, due to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions and cancer are expected to witness substantial growth over the forecast period. Increasing incidences of cardio …
- 外来外科センターの世界市場2016-2020:専門センター、総合センターAbout Ambulatory Surgical Centers The ASCs conduct surgeries in outpatient settings to help patients save on cost and duration of the treatment. This is a quickly growing healthcare provider setting, which has advanced operating equipment, specialist surgeons, operating and recovery rooms. Also, compared to hospitals, these facilities have a lesser risk of hospital acquired infections (HAIs). In h …
- 定量ポンプの世界市場:ダイヤフラム、プランジャ/ピストンThe total market of metering pumps was estimated at USD 3.44 billion globally in 2014. Asia-Pacific was the largest market of metering pumps, accounting for around 38% of the global market and is projected to register a CAGR of more than 6% between 2015 and 2020. Europe accounted for the second largest share of metering pumps market in 2014. Demand for metering pumps is expected to increase with t …
- 世界のコーティング添加剤市場Coating additives are specially engineered and developed materials, witnessing growth in market demand. This growth is driven by the end-user segments where they are being used extensively owing to their ability to improve the performance of the coating chemically, and make it visually appealing. Coating additives contribute towards the improvement of factors that affect the performance of coating …
- ブラジル・ロシア・インド・中国の外傷固定手術動向(~2020)BRIC Trauma Fixation Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Trauma Fixation Procedures Outlook to 2020", provides key procedures data on the BRIC Trauma Fixation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide informatio …
- 電気自動車(EV)用トランスミッションの世界市場2016-2020About EV Transmission The popularity of electric vehicles (EVs) as a greener option to curb environmental pollution has shot up in recent times. There has been a shift in public perception from disapproving electric vehicles as costly and inferior in terms of quality such as power, efficiency, and comfort to a more viable option for transportation. Electric cars are powered by electric motors, unl …
- SandRidge Energy, Inc.:石油・ガスバリューチェーン分析レポート2013SandRidge Energy, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "SandRidge Energy, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “SandRidge Energy, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- 乳製品の世界市場:タイプ(ラクターゼ、キモシン、微生物レンネット、リパーゼ)、用途別(ミルク、チーズ、アイスクリーム・デザート、調整粉乳、ホエー、ヨーグルト)、由来別(植物、動物・微生物)、地域別予測Global Dairy food Market to reach USD 968.9 Million by 2025. Global Dairy food Market valued approximately USD 484.7 Million in 2016 is anticipated to grow with a healthy growth rate of more than 8.00% over the forecast period 2017-2025. Key factors which gives growth to the Dairy food market are Growing world population base, rise in per capita income, increase in consumer awareness level regardi …
- ゲーム産業におけるAR(拡張現実)の世界市場About Augmented Reality Market for Gaming AR technology blends digital content with the physical world. It allows users to scan the physical environment and provides an enhanced or augmented experience by adding virtual computer-generated information. End-users can make use of this technology through apps developed for mobile devices. Gaming is an important consumer segment that AR can revolutioni …
- オートインジェクターの世界市場予測(~2023年):関節リウマチ、多発性硬化症、アナフィラキシー、心臓血管疾患、乾癬、片頭痛The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from USD 28.91 billion in 2018 at a CAGR of 24.2% during the forecast period. The growth of this market is primarily driven by factors such as the growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and the availability of generic versions of autoinjecto …
- スマートウォーターメーターの世界市場予測(~2024年)“The smart water metering market is projected to grow at a CAGR of 10.3% from 2019 to 2024” The smart water metering market is projected to reach USD 9.6 billion by 2024 from an estimated USD 5.9 billion in 2019, at a CAGR of 10.3% during the forecast period. Utilities focusing on reducing nonrevenue water rates is driving the smart water metering market. Further, rising demand for managing water …
- オストミー製品の世界市場:人工肛門用バッグ、イレオストミー用バッグ、人工膀胱用バッグ、オストミーケア用アクセサリー、医療デバイスAbout Ostomy Products Ostomy refers to a surgically made opening (stoma) in the body for the excretion of waste products such as stools, mucus, and urine. Ostomy is helpful in the treatment of intestinal and bladder diseases. An ostomy can be a temporary or permanent procedure, depending on the type of condition and the needs of patients. There are three types of ostomy: colostomy, ileostomy, and …